Copenhagen, Denmark; January 9, 2014 – Genmab A/S (OMX: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco at 9:00AM PST / 6:00PM CET on January 16, 2014. A webcast of the presentation will be available on Genmab’s website at http://ir.genmab.com/events.cfm.